Advantis Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ADVT research report →
About the company
Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions.
- CEO
- Vasilis Gregoriou
- IPO
- 1996
- Employees
- 5
- HQ
- Newport Beach, CA, US
Price Chart
- Market Cap
- $9.79K
- P/E
- -0.41
- P/S
- 0.01
- P/B
- -0.01
- EV/EBITDA
- -18.69
- Div Yield
- 0.00%
- Gross Margin
- 92.26%
- Op Margin
- -2.78%
- Net Margin
- -2.86%
- ROE
- 1.85%
- ROIC
- 4.00%
- Revenue
- $826.99K · 103.59%
- Net Income
- $-23,644 · 79.20%
- EPS
- $-0.00 · 75.84%
- Op Income
- $-22,970
- FCF YoY
- 0.00%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 51.95
- Avg Volume
- 138.43K
Get TickerSpark's AI analysis on ADVT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ADVT coverage
Recent articles, reports, and earnings notes.
No research on ADVT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ADVT report →Similar companies
Peers in the same neighborhood.